IL-33 enhances mucosal defenses against intestinal parasites and bacteria, as described for Toxoplasma gondii (162), Pseudomonas aeruginosa (163), and Leptospira (164) infection, indicating a primary role in mucosal protection. Here, IL33 is linked to infection.